caprotec bioanalytics GmbH announced that it has successfully completed a research collaboration with F. Hoffmann-La Roche, Basel, Switzerland. Under the collaboration research agreement, caprotec used its proprietary CCMS (Capture Compound Mass Spectrometry) technology to analyze the binding charac more
Clinical Trials
News Clinical Trials
-
caprotec bioanalytics Announces the Successful Completion of a Collaborative Research Project With Roche
-
Epigenomics AG Successfully Validates Lung Cancer Test in Clinical Trial
Epigenomics AG successfully completed the pivotal performance evaluation study for its Epi proLung BL Reflex Assay, a lung cancer diagnostic test. The test determines the DNA methylation status of the SHOX2 gene in bronchial lavage material routinely obtained during the clinical workup of patients more
-
Zetiq Technologies and Biomics Biotechnologies Sign Collaboration Agreement
Bio-Light announces the signing of a collaboration agreement between its subsidiary, Zetiq Technologies, and the Chinese company, Biomics Biotechnologies, whose expertise lies in the development and sales of medical and diagnostic products. This follows a memorandum of understanding signed between t more
Websites Clinical Trials
Altair Therapeutics Inc. - Leadership in Respiratory Disease Therapy
Contact Us Business Development Future Products Lead Product Target Pre-clinical Summary Clinical Studies Technology Team Management Team Board of Directors Scientific Advisors Home News & Events Leadership in Respiratory Disease Therapy Altair Therapeutics, Inc. is a biopharmaceutical company devel more
Bachem peptide neuropeptide neuropeptides biochemicals peptides
WHAT'S NEW ONLINE CATALOG CUSTOM SYNTHESIS ANALYTICAL DATA SHEET (ADS) SERVICES TECHNICAL LIBRARY DOCUMENTS SITEMAP JOBS CONTACT BOOKMARK & SHARE © Bachem Holding AG Bachem - # 1 in Peptides # 1 in large scale GMP Peptide Production more # 1 in Regulat more
Bradmer Pharmaceuticals
HOME INVESTORS ABOUT US Bradmer Pharmaceuticals, Inc. is dedicated to the development and commercialization of new and innovative cancer therapies. We Identify, license, clinically test, and bring to market promising new anti-cancer drugs that have been discovered at leading a more
